Hopman Mark sold BBNX
September 2, 2025 · Form 4 insider transaction
Hopman Mark sold 848 shares of Beta Bionics, Inc. at $18.86 per share, a transaction worth $16.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
848
Price
$18.86
Total value
$16.0K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 2, 2025
Filing dateSeptember 4, 2025
Shares owned after33,284
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.; The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.